-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Dyne Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2019 to Q3 2024.
- Dyne Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $400K, unchanged year-over-year.
- Dyne Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $1.65M, a 4.9% increase year-over-year.
- Dyne Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.67M, a 0.59% decline from 2022.
- Dyne Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.68M, a 54.7% increase from 2021.
- Dyne Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.09M, a 55.4% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)